About
TheraVectys develops lentiviral vector-based immunotherapies, including prophylactic and therapeutic vaccines targeting cancers and infectious diseases such as HPV-induced cancers.
Explore THERAVECTYS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.